{"id":1197,"date":"2021-03-17T01:14:32","date_gmt":"2021-03-17T01:14:32","guid":{"rendered":"https:\/\/www.africa-press.net\/congo-kinshasa\/politique\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue"},"modified":"2021-03-17T01:25:47","modified_gmt":"2021-03-17T01:25:47","slug":"vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue","status":"publish","type":"post","link":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue","title":{"rendered":"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l’UE"},"content":{"rendered":"

Africa-Press<\/a> – Congo Kinshasa<\/a>. <\/strong><\/span>Selon l’Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d’effets secondaires ind\u00e9sirables. Une quinzaine de pays de l’UE ont r\u00e9cemment suspendu par pr\u00e9caution l’usage de ce vaccin apr\u00e8s des cas formation de caillots sanguins ou de probl\u00e8mes de coagulation.<\/b><\/p>\n

Malgr\u00e9 les inqui\u00e9tudes de plusieurs pays de l’UE, l’Agence europ\u00e9enne des m\u00e9dicaments (EMA) reste \u00ab\u00a0fermement convaincue\u00a0\u00bb des b\u00e9n\u00e9fices du vaccin AstraZeneca contre le Covid-19, a annonc\u00e9 mardi 16 mars sa directrice, apr\u00e8s le signalement de caillots sanguins possibles mais sans lien av\u00e9r\u00e9 \u00e0 ce stade.<\/p>\n

\u00ab\u00a0Nous sommes toujours fermement convaincus que les avantages du vaccin AstraZeneca dans la pr\u00e9vention du Covid-19, avec son risque associ\u00e9 d’hospitalisation et de d\u00e9c\u00e8s, l’emportent sur le risque de ces effets secondaires\u00a0\u00bb, a d\u00e9clar\u00e9 la directrice ex\u00e9cutive de l’EMA, Emer Cooke, lors d’une visioconf\u00e9rence.<\/p>\n

Une quinzaine de pays, dont l’Allemagne, la France et l’Italie, ont suspendu par pr\u00e9caution l’utilisation du vaccin AstraZeneca, apr\u00e8s le signalement de probl\u00e8mes sanguins d\u00e9tect\u00e9s chez des personnes vaccin\u00e9es, tels que des probl\u00e8mes de coagulation ou la formation de caillots (thrombose).<\/p>\n

\u00ab\u00a0\u00c0 l’heure actuelle, rien n’indique que la vaccination ait caus\u00e9 ces probl\u00e8mes. Ils n’ont pas \u00e9t\u00e9 mentionn\u00e9s dans les essais cliniques et ils ne sont pas r\u00e9pertori\u00e9s comme effets secondaires connus ou attendus\u00a0\u00bb, a indiqu\u00e9 Emer Cooke, ajoutant que l’EMA prend la situation \u00ab\u00a0tr\u00e8s au s\u00e9rieux\u00a0\u00bb.<\/p>\n

Par ailleurs, elle a pr\u00e9cis\u00e9 que l’agence \u00ab\u00a0examinait\u00a0\u00bb les effets \u00ab\u00a0ind\u00e9sirables associ\u00e9s \u00e0 tous les vaccins\u00a0\u00bb, m\u00eame si l’attention est pour le moment concentr\u00e9e sur celui d’AstraZeneca.<\/p>\n

R\u00e9union de l’OMS<\/b><\/p>\n

Les essais cliniques ont montr\u00e9 \u00ab\u00a0de tr\u00e8s petits nombres de d\u00e9veloppements de caillots sanguins\u00a0\u00bb, a-t-elle pr\u00e9cis\u00e9.<\/p>\n

Le comit\u00e9 de s\u00e9curit\u00e9 de l’EMA, dont le si\u00e8ge se trouve \u00e0 Amsterdam, se r\u00e9unissait, mardi, pour \u00e9valuer de nouvelles informations et devrait arriver \u00e0 une conclusion lors d’une r\u00e9union sp\u00e9ciale jeudi, a d\u00e9clar\u00e9 la directrice.<\/p>\n

\u00ab\u00a0C’est donc un processus continu. Je ne suis pas ici pour vous donner la mise \u00e0 jour d’un examen scientifique\u00a0\u00bb, a-t-elle pr\u00e9venu.<\/p>\n

Le groupe consultatif d’experts de l’Organisation mondiale de la sant\u00e9 (OMS) sur la vaccination s’est r\u00e9uni \u00e9galement, mardi, pour discuter du vaccin d\u00e9velopp\u00e9 par le laboratoire su\u00e9do-britannique AstraZeneca et l’universit\u00e9 d’Oxford.<\/p>\n

L’OMS a soulign\u00e9 qu’il n’y avait pas de \u00ab\u00a0rapport\u00a0\u00bb av\u00e9r\u00e9 \u00e0 ce stade entre le vaccin et de graves probl\u00e8mes sanguins observ\u00e9s chez des personnes vaccin\u00e9es.<\/p>\n

\u00ab\u00a0Un outil pr\u00e9cieux\u00a0\u00bb<\/b><\/p>\n

De son c\u00f4t\u00e9, le ministre de la Sant\u00e9, Olivier V\u00e9ran, a rappel\u00e9 que le vaccin AstraZeneca \u00e9tait \u00ab\u00a0un outil pr\u00e9cieux\u00a0\u00bb de la strat\u00e9gie fran\u00e7aise, m\u00eame si les livraisons sont inf\u00e9rieures aux engagements du laboratoire et si son utilisation est suspendue.<\/p>\n

\u00ab\u00a0Les doses qui doivent arriver dans les trois prochaines semaines sont infinit\u00e9simales – je p\u00e8se mes mots – par rapport \u00e0 l’engagement qui avait \u00e9t\u00e9 pris mais de fait, ce vaccin reste pr\u00e9cieux dans notre strat\u00e9gie\u00a0\u00bb, a-t-il d\u00e9clar\u00e9 lors des s\u00e9ances des questions au gouvernement \u00e0 l’Assembl\u00e9e nationale.<\/p>\n

\u00ab\u00a0Si les conditions sont r\u00e9unies et si l’Agence europ\u00e9enne des m\u00e9dicaments nous dit ‘vous pouvez y aller’, si les agences nationales nous disent ‘vous pouvez y aller’, alors nous dirons aux Fran\u00e7ais ‘vous pouvez y aller'\u00a0\u00bb, a-t-il ajout\u00e9.<\/p>\n","protected":false},"excerpt":{"rendered":"

Africa-Press – Congo Kinshasa. Selon l’Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d’effets secondaires ind\u00e9sirables. Une quinzaine de pays de l’UE ont r\u00e9cemment suspendu par pr\u00e9caution l’usage de ce vaccin apr\u00e8s des cas formation de caillots sanguins ou de probl\u00e8mes de coagulation. Malgr\u00e9 les inqui\u00e9tudes de plusieurs pays […]<\/p>\n","protected":false},"author":82,"featured_media":1196,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[21,11,10],"tags":[36,47,46],"class_list":["post-1197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-communaute","category-homepage-french","category-toutes-les-actualites","tag-africa-press","tag-africa-press-congo-kinshasa","tag-congo-kinshasa"],"yoast_head":"\nVaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE - Congo-kinshasa<\/title>\n<meta name=\"description\" content=\"Selon l'Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d'effets ...\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE\" \/>\n<meta property=\"og:description\" content=\"Selon l'Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d'effets ...\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue\" \/>\n<meta property=\"og:site_name\" content=\"Congo-kinshasa\" \/>\n<meta property=\"article:published_time\" content=\"2021-03-17T01:14:32+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2021-03-17T01:25:47+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1278\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"cfeditorfr\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"cfeditorfr\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue\"},\"author\":{\"name\":\"cfeditorfr\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"headline\":\"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l’UE\",\"datePublished\":\"2021-03-17T01:14:32+00:00\",\"dateModified\":\"2021-03-17T01:25:47+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue\"},\"wordCount\":635,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg\",\"keywords\":[\"Africa Press\",\"Africa Press-Congo Kinshasa\",\"Congo Kinshasa\"],\"articleSection\":[\"Communaut\u00e9\",\"homepage-french\",\"Toutes les actualit\u00e9s\"],\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue\",\"url\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue\",\"name\":\"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE - Congo-kinshasa\",\"isPartOf\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage\"},\"thumbnailUrl\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg\",\"datePublished\":\"2021-03-17T01:14:32+00:00\",\"dateModified\":\"2021-03-17T01:25:47+00:00\",\"author\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\"},\"description\":\"Selon l'Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d'effets ...\",\"breadcrumb\":{\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage\",\"url\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg\",\"contentUrl\":\"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg\",\"width\":1920,\"height\":1278,\"caption\":\"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l’UE\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#website\",\"url\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/\",\"name\":\"Congo-kinshasa\",\"description\":\"Just another Africa News Agency Sites site\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1\",\"name\":\"cfeditorfr\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE - Congo-kinshasa","description":"Selon l'Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d'effets ...","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue","og_locale":"fr_FR","og_type":"article","og_title":"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE","og_description":"Selon l'Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d'effets ...","og_url":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue","og_site_name":"Congo-kinshasa","article_published_time":"2021-03-17T01:14:32+00:00","article_modified_time":"2021-03-17T01:25:47+00:00","og_image":[{"width":1920,"height":1278,"url":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg","type":"image\/jpeg"}],"author":"cfeditorfr","twitter_card":"summary_large_image","twitter_misc":{"\u00c9crit par":"cfeditorfr","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#article","isPartOf":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue"},"author":{"name":"cfeditorfr","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"headline":"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l’UE","datePublished":"2021-03-17T01:14:32+00:00","dateModified":"2021-03-17T01:25:47+00:00","mainEntityOfPage":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue"},"wordCount":635,"commentCount":0,"image":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg","keywords":["Africa Press","Africa Press-Congo Kinshasa","Congo Kinshasa"],"articleSection":["Communaut\u00e9","homepage-french","Toutes les actualit\u00e9s"],"inLanguage":"fr-FR","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue","url":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue","name":"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE - Congo-kinshasa","isPartOf":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage"},"image":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage"},"thumbnailUrl":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg","datePublished":"2021-03-17T01:14:32+00:00","dateModified":"2021-03-17T01:25:47+00:00","author":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1"},"description":"Selon l'Agence europ\u00e9enne du m\u00e9dicament (EMA), les b\u00e9n\u00e9fices du vaccin AstraZeneca sont sup\u00e9rieurs au risque d'effets ...","breadcrumb":{"@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#primaryimage","url":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg","contentUrl":"https:\/\/static.africa-press.net\/centrafricaine\/sites\/49\/2021\/03\/img-60515a821695c.jpg","width":1920,"height":1278,"caption":"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l'UE"},{"@type":"BreadcrumbList","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/toutes-les-actualites\/vaccin-astrazeneca-les-avantages-restent-superieurs-aux-risques-dit-le-regulateur-de-lue#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/www.africa-press.net\/congo-kinshasa\/"},{"@type":"ListItem","position":2,"name":"Vaccin AstraZeneca : les avantages restent sup\u00e9rieurs aux risques, dit le r\u00e9gulateur de l’UE"}]},{"@type":"WebSite","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#website","url":"https:\/\/www.africa-press.net\/congo-kinshasa\/","name":"Congo-kinshasa","description":"Just another Africa News Agency Sites site","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.africa-press.net\/congo-kinshasa\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/www.africa-press.net\/congo-kinshasa\/#\/schema\/person\/2b1cf3cd81a31e3cd26889ca66d677f1","name":"cfeditorfr"}]}},"_links":{"self":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/posts\/1197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/users\/82"}],"replies":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/comments?post=1197"}],"version-history":[{"count":0,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/posts\/1197\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/media\/1196"}],"wp:attachment":[{"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/media?parent=1197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/categories?post=1197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.africa-press.net\/congo-kinshasa\/wp-json\/wp\/v2\/tags?post=1197"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}